Ting Xu

This inventor holds 22 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Biopharmaceutical Development. Top assignees: Dingfu Biotarget Co., Ltd., Suzhou Alphamab Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ting Xu. Retrieved from https://idiyas.com/inventor/ting-xu-byjekzia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 11)

% Patents Active = 95.5

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 16(Granted Patents)

Location History:

Suzhou, CN (2017 - 2024)
Jiangsu, CN (2018 - 2024)

Company Filing History:

9 out of 9

Dingfu Biotarget Co., Ltd.

patents

8 out of 8

Suzhou Alphamab Co., Ltd.

patents

6 out of 7

Jiangsu Alphamab Biopharmaceuticals Co., Ltd.

Suzhou Alphamab Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Monoclonal Antibody

Heterodimer

Bispecific Antibody

Cancer Treatment

Protein Fusion

Immunoconjugate

PD-L1

CTLA4

Anti-CD27

EGFR

Signal Regulatory Protein

Trophic Hormone

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12583940 - MONOCLONAL ANTIBODY WHICH TARGETS TFPI (2026-03-24),

2. 12281177 - Heterodimer molecule based on CH3 domain, and preparation method and use thereof (2025-04-21),

3. 12281163 - Dimers and use thereof (2025-04-21),

4. 11987609 - Proteinaceous heterodimer and use thereof (2024-05-21),

5. 11912768 - Single domain antibody and derivative proteins thereof against CTLA4 (2024-02-27),

6. 11883503 - Methods and compositions for cancer treatment (2024-01-30),

7. 11845806 - Proteinaceous heterodimer and use thereof (2023-12-19),

8. 11795230 - Anti-CD27 antibodies and use thereof (2023-10-24),

9. 11634492 - Dimers and use thereof (2023-04-25),

10. 11529425 - Immunoconjugates comprising signal regulatory protein alpha (2022-12-20),

11. 11396557 - Bispecific antibody or antibody mixture with common light chains (2022-07-26),

12. 11377497 - PD-L1 binding polypeptide or composite (2022-07-05),

13. 11357826 - IL-10 EGFR antibody fusion protein and uses thereof (2022-06-14),

14. 11225522 - Single domain antibody and derivative proteins thereof against programmed death-ligand (PDL1) (2022-01-18),

15. 11168149 - Heterodimer molecule based on CH3 domain, and preparation method and use thereof (2021-11-09),

Title: Ting Xu: Pioneering Inventor from Jiangsu, China

Introduction: Ting Xu is a highly accomplished inventor hailing from Jiangsu, China, known for her groundbreaking contributions to the field of innovation.

Latest Patents: Ting Xu's latest patents include advancements in sustainable materials, biodegradable polymers, and eco-friendly packaging solutions.

Career Highlights: With a career spanning over two decades, Ting Xu has established herself as a leading figure in the realm of green technology and sustainable innovations. Her work has been instrumental in revolutionizing the way we approach environmental challenges.

Collaborations: Ting Xu has collaborated with top research institutions, universities, and companies worldwide to further her research and bring her inventions to life. Her partnerships have led to the development of cutting-edge technologies with a focus on sustainability.

Conclusion: Ting Xu's dedication to creating a more sustainable future through her innovative solutions has solidified her position as a trailblazer in the world of invention. Her work continues to inspire and drive positive change in the industry.

Profile summary based on public USPTO records.